| Symbol |
Name |
|
AASTH42
|
Allergic/atopic asthma related QTL 42
|
|
ABCB1
|
ATP-binding cassette, sub-family B (MDR/TAP), member 1
|
|
ABCB11
|
ATP-binding cassette, sub-family B (MDR/TAP), member 11
|
|
ABCC5
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 5
|
|
ABCC6
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 6
|
|
ABCC8
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 8
|
|
ABO
|
ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)
|
|
ACAA2
|
acetyl-CoA acyltransferase 2
|
|
ACAN
|
aggrecan
|
|
ACE
|
angiotensin I converting enzyme
|
|
ACTN1
|
actinin, alpha 1
|
|
ACTN2
|
actinin, alpha 2
|
|
ACVR1
|
activin A receptor, type I
|
|
ADA
|
adenosine deaminase
|
|
ADAD1
|
adenosine deaminase domain containing 1 (testis-specific)
|
|
ADCY9
|
adenylate cyclase 9
|
|
ADH1C
|
alcohol dehydrogenase 1C (class I), gamma polypeptide
|
|
ADIPOQ
|
adiponectin, C1Q and collagen domain containing
|
|
ADIPOR2
|
adiponectin receptor 2
|
|
ADM
|
adrenomedullin
|
|
ADORA2A
|
adenosine A2a receptor
|
|
ADRA1A
|
adrenoceptor alpha 1A
|
|
ADRA2A
|
adrenoceptor alpha 2A
|
|
ADRB2
|
adrenoceptor beta 2, surface
|
|
AGT
|
angiotensinogen (serpin peptidase inhibitor, clade A, member 8)
|
|
AGTR1
|
angiotensin II receptor, type 1
|
|
AICDA
|
activation-induced cytidine deaminase
|
|
AIF1
|
allograft inflammatory factor 1
|
|
AKAP13
|
A kinase (PRKA) anchor protein 13
|
|
ALDH2
|
aldehyde dehydrogenase 2 family (mitochondrial)
|
|
ALPP
|
alkaline phosphatase, placental
|
|
ANGPT1
|
angiopoietin 1
|
|
ANGPT4
|
angiopoietin 4
|
|
ANIB1
|
aneurysm, intracranial berry 1
|
|
ANKK1
|
ankyrin repeat and kinase domain containing 1
|
|
APC
|
adenomatous polyposis coli
|
|
APEX1
|
APEX nuclease (multifunctional DNA repair enzyme) 1
|
|
APOA1
|
apolipoprotein A-I
|
|
APOA4
|
apolipoprotein A-IV
|
|
APOA5
|
apolipoprotein A-V
|
|
APOB
|
apolipoprotein B
|
|
APOBEC3H
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3H
|
|
APOC1
|
apolipoprotein C-I
|
|
APOC3
|
apolipoprotein C-III
|
|
APOE
|
apolipoprotein E
|
|
APP
|
amyloid beta (A4) precursor protein
|
|
AR
|
androgen receptor
|
|
ARF6
|
ADP-ribosylation factor 6
|
|
ARHGEF28
|
Rho guanine nucleotide exchange factor (GEF) 28
|
|
ARNT
|
aryl hydrocarbon receptor nuclear translocator
|
|
ART1
|
ADP-ribosyltransferase 1
|
|
ARVCF
|
armadillo repeat gene deleted in velocardiofacial syndrome
|
|
ATM
|
ATM serine/threonine kinase
|
|
ATN1
|
atrophin 1
|
|
ATP1A2
|
ATPase, Na+/K+ transporting, alpha 2 polypeptide
|
|
ATXN1
|
ataxin 1
|
|
ATXN3
|
ataxin 3
|
|
AURKB
|
aurora kinase B
|
|
AUTS1
|
Autism, susceptibility to, 1
|
|
AUTS5
|
Autism, susceptibility to, 5
|
|
AVPR1A
|
arginine vasopressin receptor 1A
|
|
B3GAT3
|
beta-1,3-glucuronyltransferase 3
|
|
BAG4
|
BCL2-associated athanogene 4
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BDNF
|
brain-derived neurotrophic factor
|
|
BDP1
|
B double prime 1, subunit of RNA polymerase III transcription initiation factor IIIB
|
|
BLM
|
Bloom syndrome, RecQ helicase-like
|
|
BMP4
|
bone morphogenetic protein 4
|
|
BMPR1A
|
bone morphogenetic protein receptor, type IA
|
|
BMPR1B
|
bone morphogenetic protein receptor, type IB
|
|
BNIP1
|
BCL2/adenovirus E1B 19kDa interacting protein 1
|
|
BNIP3
|
BCL2/adenovirus E1B 19kDa interacting protein 3
|
|
BP33
|
Blood pressure QTL 33
|
|
BRCA1
|
breast cancer 1, early onset
|
|
BRCA2
|
breast cancer 2, early onset
|
|
BRCATA
|
Breast cancer, 11;22 translocation associated
|
|
BRD2
|
bromodomain containing 2
|
|
BTNL2
|
butyrophilin-like 2
|
|
BUD13
|
BUD13 homolog (S. cerevisiae)
|
|
C2
|
complement component 2
|
|
C3
|
complement component 3
|
|
CACNA1A
|
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit
|
|
CACNA1C
|
calcium channel, voltage-dependent, L type, alpha 1C subunit
|
|
CACNA1G
|
calcium channel, voltage-dependent, T type, alpha 1G subunit
|
|
CACNA1H
|
calcium channel, voltage-dependent, T type, alpha 1H subunit
|
|
CACNG3
|
calcium channel, voltage-dependent, gamma subunit 3
|
|
CALCRL
|
calcitonin receptor-like
|
|
CAPN10
|
calpain 10
|
|
CARD14
|
caspase recruitment domain family, member 14
|
|
CASP3
|
caspase 3, apoptosis-related cysteine peptidase
|
|
CAST
|
calpastatin
|
|
CCL8
|
chemokine (C-C motif) ligand 8
|
|
CCND1
|
cyclin D1
|
|
CCR1
|
chemokine (C-C motif) receptor 1
|
|
CCR2
|
chemokine (C-C motif) receptor 2
|
|
CCR5
|
chemokine (C-C motif) receptor 5 (gene/pseudogene)
|
|
CD24
|
CD24 molecule
|
|
CD28
|
CD28 molecule
|
|
CD44
|
CD44 molecule (Indian blood group)
|
|
CD63
|
CD63 molecule
|
|
CD79B
|
CD79b molecule, immunoglobulin-associated beta
|
|
CDH5
|
cadherin 5, type 2 (vascular endothelium)
|
|
CDK2
|
cyclin-dependent kinase 2
|
|
CDK4
|
cyclin-dependent kinase 4
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CEBPB
|
CCAAT/enhancer binding protein (C/EBP), beta
|
|
CERS4
|
ceramide synthase 4
|
|
CETP
|
cholesteryl ester transfer protein, plasma
|
|
CFB
|
complement factor B
|
|
CFTR
|
cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)
|
|
CGNL1
|
cingulin-like 1
|
|
CHAT
|
choline O-acetyltransferase
|
|
CHD7
|
chromodomain helicase DNA binding protein 7
|
|
CHED1
|
corneal endothelial dystrophy 1 (autosomal dominant)
|
|
CHEK2
|
checkpoint kinase 2
|
|
CHRM2
|
cholinergic receptor, muscarinic 2
|
|
CHRNA7
|
cholinergic receptor, nicotinic, alpha 7 (neuronal)
|
|
CHST10
|
carbohydrate sulfotransferase 10
|
|
CHST3
|
carbohydrate (chondroitin 6) sulfotransferase 3
|
|
CIITA
|
class II, major histocompatibility complex, transactivator
|
|
CLEC16A
|
C-type lectin domain family 16, member A
|
|
CLINT1
|
clathrin interactor 1
|
|
CNA1
|
cornea plana 1 (autosomal dominant)
|
|
CNBP
|
CCHC-type zinc finger, nucleic acid binding protein
|
|
COL1A2
|
collagen, type I, alpha 2
|
|
COL2A1
|
collagen, type II, alpha 1
|
|
COL6A1
|
collagen, type VI, alpha 1
|
|
COL6A2
|
collagen, type VI, alpha 2
|
|
COL6A3
|
collagen, type VI, alpha 3
|
|
COL8A1
|
collagen, type VIII, alpha 1
|
|
COMT
|
catechol-O-methyltransferase
|
|
CPB2
|
carboxypeptidase B2 (plasma)
|
|
CRHR1
|
corticotropin releasing hormone receptor 1
|
|
CRP
|
C-reactive protein, pentraxin-related
|
|
CRY1
|
cryptochrome circadian clock 1
|
|
CRYAB
|
crystallin, alpha B
|
|
CSF1R
|
colony stimulating factor 1 receptor
|
|
CSRP3
|
cysteine and glycine-rich protein 3 (cardiac LIM protein)
|
|
CST3
|
cystatin C
|
|
CTLA4
|
cytotoxic T-lymphocyte-associated protein 4
|
|
CTNNA1
|
catenin (cadherin-associated protein), alpha 1, 102kDa
|
|
CTNNA3
|
catenin (cadherin-associated protein), alpha 3
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
CTNNBL1
|
catenin, beta like 1
|
|
CTNND2
|
catenin (cadherin-associated protein), delta 2
|
|
CUBN
|
cubilin (intrinsic factor-cobalamin receptor)
|
|
CX3CL1
|
chemokine (C-X3-C motif) ligand 1
|
|
CXCR1
|
chemokine (C-X-C motif) receptor 1
|
|
CXCR2
|
chemokine (C-X-C motif) receptor 2
|
|
CYP11B1
|
cytochrome P450, family 11, subfamily B, polypeptide 1
|
|
CYP11B2
|
cytochrome P450, family 11, subfamily B, polypeptide 2
|
|
CYP19A1
|
cytochrome P450, family 19, subfamily A, polypeptide 1
|
|
CYP1A2
|
cytochrome P450, family 1, subfamily A, polypeptide 2
|
|
CYP2C19
|
cytochrome P450, family 2, subfamily C, polypeptide 19
|
|
CYP2C8
|
cytochrome P450, family 2, subfamily C, polypeptide 8
|
|
CYP2C9
|
cytochrome P450, family 2, subfamily C, polypeptide 9
|
|
CYP2D6
|
cytochrome P450, family 2, subfamily D, polypeptide 6
|
|
CYP2E1
|
cytochrome P450, family 2, subfamily E, polypeptide 1
|
|
CYP3A4
|
cytochrome P450, family 3, subfamily A, polypeptide 4
|
|
CYP3A5
|
cytochrome P450, family 3, subfamily A, polypeptide 5
|
|
CYP3A7
|
cytochrome P450, family 3, subfamily A, polypeptide 7
|
|
DBH
|
dopamine beta-hydroxylase (dopamine beta-monooxygenase)
|
|
DCAF4L2
|
DDB1 and CUL4 associated factor 4-like 2
|
|
DCC
|
DCC netrin 1 receptor
|
|
DCN
|
decorin
|
|
DDIT3
|
DNA-damage-inducible transcript 3
|
|
DEK
|
DEK proto-oncogene
|
|
DES
|
desmin
|
|
DFNA18
|
deafness, autosomal dominant 18
|
|
DFNA27
|
deafness, autosomal dominant 27
|
|
DFNA5
|
deafness, autosomal dominant 5
|
|
DGKI
|
diacylglycerol kinase, iota
|
|
DIAPH2
|
diaphanous-related formin 2
|
|
DISC1
|
disrupted in schizophrenia 1
|
|
DLST
|
dihydrolipoamide S-succinyltransferase (E2 component of 2-oxo-glutarate complex)
|
|
DLX6
|
distal-less homeobox 6
|
|
DMD
|
dystrophin
|
|
DNMBP
|
dynamin binding protein
|
|
DNMT3B
|
DNA (cytosine-5-)-methyltransferase 3 beta
|
|
DPP4
|
dipeptidyl-peptidase 4
|
|
DRD2
|
dopamine receptor D2
|
|
DRD3
|
dopamine receptor D3
|
|
DRD4
|
dopamine receptor D4
|
|
DRD5
|
dopamine receptor D5
|
|
DTNBP1
|
dystrobrevin binding protein 1
|
|
DUOX2
|
dual oxidase 2
|
|
EBF1
|
early B-cell factor 1
|
|
EDN1
|
endothelin 1
|
|
EGFR
|
epidermal growth factor receptor
|
|
EIF4G1
|
eukaryotic translation initiation factor 4 gamma, 1
|
|
EMILIN1
|
elastin microfibril interfacer 1
|
|
ENG
|
endoglin
|
|
EPAS1
|
endothelial PAS domain protein 1
|
|
EPYC
|
epiphycan
|
|
ERAP2
|
endoplasmic reticulum aminopeptidase 2
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ERBB4
|
erb-b2 receptor tyrosine kinase 4
|
|
ERCC2
|
excision repair cross-complementation group 2
|
|
ERG
|
v-ets avian erythroblastosis virus E26 oncogene homolog
|
|
ESR1
|
estrogen receptor 1
|
|
ETS2
|
v-ets avian erythroblastosis virus E26 oncogene homolog 2
|
|
EVC2
|
Ellis van Creveld syndrome 2
|
|
EXT1
|
exostosin glycosyltransferase 1
|
|
EXT2
|
exostosin glycosyltransferase 2
|
|
EYS
|
eyes shut homolog (Drosophila)
|
|
F10
|
coagulation factor X
|
|
F11
|
coagulation factor XI
|
|
F12
|
coagulation factor XII (Hageman factor)
|
|
F5
|
coagulation factor V (proaccelerin, labile factor)
|
|
F7
|
coagulation factor VII (serum prothrombin conversion accelerator)
|
|
F8
|
coagulation factor VIII, procoagulant component
|
|
F9
|
coagulation factor IX
|
|
FAF1
|
Fas (TNFRSF6) associated factor 1
|
|
FAM168A
|
family with sequence similarity 168, member A
|
|
FAP
|
fibroblast activation protein, alpha
|
|
FAS
|
Fas cell surface death receptor
|
|
FASLG
|
Fas ligand (TNF superfamily, member 6)
|
|
FBLIM1
|
filamin binding LIM protein 1
|
|
FBN1
|
fibrillin 1
|
|
FCER1A
|
Fc fragment of IgE, high affinity I, receptor for; alpha polypeptide
|
|
FCGR2A
|
Fc fragment of IgG, low affinity IIa, receptor (CD32)
|
|
FCGR3A
|
Fc fragment of IgG, low affinity IIIa, receptor (CD16a)
|
|
FCGR3B
|
Fc fragment of IgG, low affinity IIIb, receptor (CD16b)
|
|
FCN2
|
ficolin (collagen/fibrinogen domain containing lectin) 2
|
|
FCRL3
|
Fc receptor-like 3
|
|
FCRL5
|
Fc receptor-like 5
|
|
FERMT1
|
fermitin family member 1
|
|
FGB
|
fibrinogen beta chain
|
|
FGF10
|
fibroblast growth factor 10
|
|
FGFR1
|
fibroblast growth factor receptor 1
|
|
FHIT
|
fragile histidine triad
|
|
FILIP1L
|
filamin A interacting protein 1-like
|
|
FLG
|
filaggrin
|
|
FMO3
|
flavin containing monooxygenase 3
|
|
FMR1
|
fragile X mental retardation 1
|
|
FOXE1
|
forkhead box E1
|
|
FRAXA
|
fragile site, folic acid type, rare, fra(X)(q27.3) A (macroorchidism, mental retardation)
|
|
FSHR
|
follicle stimulating hormone receptor
|
|
FTO
|
fat mass and obesity associated
|
|
FUT3
|
fucosyltransferase 3 (galactoside 3(4)-L-fucosyltransferase, Lewis blood group)
|
|
G6PC
|
glucose-6-phosphatase, catalytic subunit
|
|
G6PC2
|
glucose-6-phosphatase, catalytic, 2
|
|
G6PD
|
glucose-6-phosphate dehydrogenase
|
|
GABRA2
|
gamma-aminobutyric acid (GABA) A receptor, alpha 2
|
|
GABRB1
|
gamma-aminobutyric acid (GABA) A receptor, beta 1
|
|
GABRB3
|
gamma-aminobutyric acid (GABA) A receptor, beta 3
|
|
GABRG1
|
gamma-aminobutyric acid (GABA) A receptor, gamma 1
|
|
GABRG2
|
gamma-aminobutyric acid (GABA) A receptor, gamma 2
|
|
GAD1
|
glutamate decarboxylase 1 (brain, 67kDa)
|
|
GADD45G
|
growth arrest and DNA-damage-inducible, gamma
|
|
GALNT1
|
polypeptide N-acetylgalactosaminyltransferase 1
|
|
GATA3
|
GATA binding protein 3
|
|
GATA4
|
GATA binding protein 4
|
|
GBA
|
glucosidase, beta, acid
|
|
GCA
|
grancalcin, EF-hand calcium binding protein
|
|
GCK
|
glucokinase (hexokinase 4)
|
|
GCKR
|
glucokinase (hexokinase 4) regulator
|
|
GFRA1
|
GDNF family receptor alpha 1
|
|
GFRA2
|
GDNF family receptor alpha 2
|
|
GFRA3
|
GDNF family receptor alpha 3
|
|
GGT1
|
gamma-glutamyltransferase 1
|
|
GH1
|
growth hormone 1
|
|
GHR
|
growth hormone receptor
|
|
GHRL
|
ghrelin/obestatin prepropeptide
|
|
GIGYF2
|
GRB10 interacting GYF protein 2
|
|
GIPC3
|
GIPC PDZ domain containing family, member 3
|
|
GJB2
|
gap junction protein, beta 2, 26kDa
|
|
GJC2
|
gap junction protein, gamma 2, 47kDa
|
|
GNA11
|
guanine nucleotide binding protein (G protein), alpha 11 (Gq class)
|
|
GNA14
|
guanine nucleotide binding protein (G protein), alpha 14
|
|
GNA15
|
guanine nucleotide binding protein (G protein), alpha 15 (Gq class)
|
|
GNAS
|
GNAS complex locus
|
|
GNE
|
glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase
|
|
GNPTAB
|
N-acetylglucosamine-1-phosphate transferase, alpha and beta subunits
|
|
GNRHR
|
gonadotropin-releasing hormone receptor
|
|
GP5
|
glycoprotein V (platelet)
|
|
GP9
|
glycoprotein IX (platelet)
|
|
GRIK2
|
glutamate receptor, ionotropic, kainate 2
|
|
GRIK3
|
glutamate receptor, ionotropic, kainate 3
|
|
GRIN2A
|
glutamate receptor, ionotropic, N-methyl D-aspartate 2A
|
|
GRIN2B
|
glutamate receptor, ionotropic, N-methyl D-aspartate 2B
|
|
GSG2
|
germ cell associated 2 (haspin)
|
|
GSTZ1
|
glutathione S-transferase zeta 1
|
|
H2AFX
|
H2A histone family, member X
|
|
HAMP
|
hepcidin antimicrobial peptide
|
|
HAND2
|
heart and neural crest derivatives expressed 2
|
|
HAVCR2
|
hepatitis A virus cellular receptor 2
|
|
HBB
|
hemoglobin, beta
|
|
HFE
|
hemochromatosis
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
|
HLA-A
|
major histocompatibility complex, class I, A
|
|
HLA-B
|
major histocompatibility complex, class I, B
|
|
HLA-C
|
major histocompatibility complex, class I, C
|
|
HLA-DPB1
|
major histocompatibility complex, class II, DP beta 1
|
|
HLA-DQA1
|
major histocompatibility complex, class II, DQ alpha 1
|
|
HLA-DQB1
|
major histocompatibility complex, class II, DQ beta 1
|
|
HLA-DRB1
|
major histocompatibility complex, class II, DR beta 1
|
|
HLA-DRB3
|
major histocompatibility complex, class II, DR beta 3
|
|
HLA-DRB5
|
major histocompatibility complex, class II, DR beta 5
|
|
HLA-E
|
major histocompatibility complex, class I, E
|
|
HLA-G
|
major histocompatibility complex, class I, G
|
|
HMGXB4
|
HMG box domain containing 4
|
|
HMX1
|
H6 family homeobox 1
|
|
HNF4A
|
hepatocyte nuclear factor 4, alpha
|
|
HOXA1
|
homeobox A1
|
|
HOXA10
|
homeobox A10
|
|
HOXD10
|
homeobox D10
|
|
HSPB1
|
heat shock 27kDa protein 1
|
|
HTR1B
|
5-hydroxytryptamine (serotonin) receptor 1B, G protein-coupled
|
|
HTR2C
|
5-hydroxytryptamine (serotonin) receptor 2C, G protein-coupled
|
|
HTRA1
|
HtrA serine peptidase 1
|
|
HTT
|
huntingtin
|
|
HYAL4
|
hyaluronoglucosaminidase 4
|
|
IBD5
|
inflammatory bowel disease 5
|
|
ICAM1
|
intercellular adhesion molecule 1
|
|
ICAM2
|
intercellular adhesion molecule 2
|
|
ICOS
|
inducible T-cell co-stimulator
|
|
IDDM17
|
insulin-dependent diabetes mellitus 17
|
|
IDDM9
|
insulin-dependent diabetes mellitus 9
|
|
IDE
|
insulin-degrading enzyme
|
|
IFIH1
|
interferon induced with helicase C domain 1
|
|
IFNG
|
interferon, gamma
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
|
IGF2
|
insulin-like growth factor 2
|
|
IL10
|
interleukin 10
|
|
IL10RA
|
interleukin 10 receptor, alpha
|
|
IL12B
|
interleukin 12B
|
|
IL17A
|
interleukin 17A
|
|
IL1A
|
interleukin 1, alpha
|
|
IL1B
|
interleukin 1, beta
|
|
IL1RN
|
interleukin 1 receptor antagonist
|
|
IL2
|
interleukin 2
|
|
IL21
|
interleukin 21
|
|
IL23R
|
interleukin 23 receptor
|
|
IL2RB
|
interleukin 2 receptor, beta
|
|
IL36RN
|
interleukin 36 receptor antagonist
|
|
IL4
|
interleukin 4
|
|
IL4R
|
interleukin 4 receptor
|
|
IL6
|
interleukin 6
|
|
IL6ST
|
interleukin 6 signal transducer
|
|
ILK
|
integrin-linked kinase
|
|
IMMP2L
|
IMP2 inner mitochondrial membrane peptidase-like (S. cerevisiae)
|
|
INHBA
|
inhibin, beta A
|
|
INS
|
insulin
|
|
INSR
|
insulin receptor
|
|
IRAK2
|
interleukin-1 receptor-associated kinase 2
|
|
IRF5
|
interferon regulatory factor 5
|
|
IRF6
|
interferon regulatory factor 6
|
|
ISG15
|
ISG15 ubiquitin-like modifier
|
|
ITGA2
|
integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor)
|
|
ITGA4
|
integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor)
|
|
ITGB1
|
integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12)
|
|
ITPR3
|
inositol 1,4,5-trisphosphate receptor, type 3
|
|
JARID2
|
jumonji, AT rich interactive domain 2
|
|
JAZF1
|
JAZF zinc finger 1
|
|
KAT5
|
K(lysine) acetyltransferase 5
|
|
KCNH2
|
potassium channel, voltage gated eag related subfamily H, member 2
|
|
KCNJ11
|
potassium channel, inwardly rectifying subfamily J, member 11
|
|
KCNK1
|
potassium channel, two pore domain subfamily K, member 1
|
|
KDM5A
|
lysine (K)-specific demethylase 5A
|
|
KDR
|
kinase insert domain receptor
|
|
KERA
|
keratocan
|
|
KIAA1109
|
KIAA1109
|
|
KIR2DL1
|
killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 1
|
|
KIR2DL3
|
killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 3
|
|
KIR2DS2
|
killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 2
|
|
KIR2DS3
|
killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 3
|
|
KIR2DS4
|
killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 4
|
|
KIR2DS5
|
killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 5
|
|
KIR3DL1
|
killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1
|
|
KRT85
|
keratin 85, type II
|
|
LCT
|
lactase
|
|
LHB
|
luteinizing hormone beta polypeptide
|
|
LIPG
|
lipase, endothelial
|
|
LPA
|
lipoprotein, Lp(a)
|
|
LPAR6
|
lysophosphatidic acid receptor 6
|
|
LPL
|
lipoprotein lipase
|
|
LRRK2
|
leucine-rich repeat kinase 2
|
|
LRTOMT
|
leucine rich transmembrane and O-methyltransferase domain containing
|
|
LTA
|
lymphotoxin alpha
|
|
LTBP2
|
latent transforming growth factor beta binding protein 2
|
|
LUM
|
lumican
|
|
MAP2K4
|
mitogen-activated protein kinase kinase 4
|
|
MAP3K5
|
mitogen-activated protein kinase kinase kinase 5
|
|
MAPT
|
microtubule-associated protein tau
|
|
MBL2
|
mannose-binding lectin (protein C) 2, soluble
|
|
MC4R
|
melanocortin 4 receptor
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
|
MECP2
|
methyl CpG binding protein 2
|
|
MEF2A
|
myocyte enhancer factor 2A
|
|
MEX3C
|
mex-3 RNA binding family member C
|
|
MGR1
|
Migraine with aura, susceptibility to
|
|
MGRN1
|
mahogunin ring finger 1, E3 ubiquitin protein ligase
|
|
MICA
|
MHC class I polypeptide-related sequence A
|
|
MICB
|
MHC class I polypeptide-related sequence B
|
|
MIF
|
macrophage migration inhibitory factor (glycosylation-inhibiting factor)
|
|
MITF
|
microphthalmia-associated transcription factor
|
|
MLH1
|
mutL homolog 1
|
|
MLXIPL
|
MLX interacting protein-like
|
|
MME
|
membrane metallo-endopeptidase
|
|
MMP1
|
matrix metallopeptidase 1
|
|
MMP12
|
matrix metallopeptidase 12
|
|
MMP14
|
matrix metallopeptidase 14 (membrane-inserted)
|
|
MMP3
|
matrix metallopeptidase 3
|
|
MOG
|
myelin oligodendrocyte glycoprotein
|
|
MPO
|
myeloperoxidase
|
|
MSH2
|
mutS homolog 2
|
|
MST1R
|
macrophage stimulating 1 receptor
|
|
MTHFR
|
methylenetetrahydrofolate reductase (NAD(P)H)
|
|
MTNR1B
|
melatonin receptor 1B
|
|
MTO1
|
mitochondrial tRNA translation optimization 1
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
|
MTRR
|
5-methyltetrahydrofolate-homocysteine methyltransferase reductase
|
|
MTTP
|
microsomal triglyceride transfer protein
|
|
MYH9
|
myosin, heavy chain 9, non-muscle
|
|
MYO7A
|
myosin VIIA
|
|
MYOC
|
myocilin, trabecular meshwork inducible glucocorticoid response
|
|
NAA25
|
N(alpha)-acetyltransferase 25, NatB auxiliary subunit
|
|
NAMPT
|
nicotinamide phosphoribosyltransferase
|
|
NCKIPSD
|
NCK interacting protein with SH3 domain
|
|
NCSTN
|
nicastrin
|
|
NDE1
|
nudE neurodevelopment protein 1
|
|
NEB
|
nebulin
|
|
NEBL
|
nebulette
|
|
NEDD4L
|
neural precursor cell expressed, developmentally down-regulated 4-like, E3 ubiquitin protein ligase
|
|
NES
|
nestin
|
|
NEU2
|
sialidase 2 (cytosolic sialidase)
|
|
NF1
|
neurofibromin 1
|
|
NFE2L2
|
nuclear factor, erythroid 2-like 2
|
|
NFKBIL1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor-like 1
|
|
NFKBIZ
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, zeta
|
|
NOD2
|
nucleotide-binding oligomerization domain containing 2
|
|
NOS1AP
|
nitric oxide synthase 1 (neuronal) adaptor protein
|
|
NOS2
|
nitric oxide synthase 2, inducible
|
|
NOTCH1
|
notch 1
|
|
NOTCH4
|
notch 4
|
|
NPPA
|
natriuretic peptide A
|
|
NPPB
|
natriuretic peptide B
|
|
NR3C1
|
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)
|
|
NRG1
|
neuregulin 1
|
|
NRG2
|
neuregulin 2
|
|
NTM
|
neurotrimin
|
|
NTN1
|
netrin 1
|
|
NTRK1
|
neurotrophic tyrosine kinase, receptor, type 1
|
|
NTRK2
|
neurotrophic tyrosine kinase, receptor, type 2
|
|
NUCLEOLIN
|
nucleolin multifunctional protein
|
|
OGG1
|
8-oxoguanine DNA glycosylase
|
|
OPRD1
|
opioid receptor, delta 1
|
|
OSBPL10
|
oxysterol binding protein-like 10
|
|
OTSC3
|
otosclerosis 3
|
|
OTSC4
|
otosclerosis 4
|
|
OTSC7
|
otosclerosis 7
|
|
P2RY1
|
purinergic receptor P2Y, G-protein coupled, 1
|
|
P2RY12
|
purinergic receptor P2Y, G-protein coupled, 12
|
|
PAFAH1B2
|
platelet-activating factor acetylhydrolase 1b, catalytic subunit 2 (30kDa)
|
|
PANX1
|
pannexin 1
|
|
PARK16
|
Parkinson disease 16 (susceptibility)
|
|
PARK2
|
parkin RBR E3 ubiquitin protein ligase
|
|
PARK3
|
Parkinson disease 3 (autosomal dominant, Lewy body)
|
|
PARK7
|
parkinson protein 7
|
|
PARP1
|
poly (ADP-ribose) polymerase 1
|
|
PARVB
|
parvin, beta
|
|
PAX6
|
paired box 6
|
|
PAX7
|
paired box 7
|
|
PDE4D
|
phosphodiesterase 4D, cAMP-specific
|
|
PDGFB
|
platelet-derived growth factor beta polypeptide
|
|
PDGFRA
|
platelet-derived growth factor receptor, alpha polypeptide
|
|
PDGFRB
|
platelet-derived growth factor receptor, beta polypeptide
|
|
PDYN
|
prodynorphin
|
|
PFKM
|
phosphofructokinase, muscle
|
|
PHIP
|
pleckstrin homology domain interacting protein
|
|
PHOX2A
|
paired-like homeobox 2a
|
|
PI4K2A
|
phosphatidylinositol 4-kinase type 2 alpha
|
|
PICALM
|
phosphatidylinositol binding clathrin assembly protein
|
|
PIK3C2A
|
phosphatidylinositol-4-phosphate 3-kinase, catalytic subunit type 2 alpha
|
|
PIKFYVE
|
phosphoinositide kinase, FYVE finger containing
|
|
PITX2
|
paired-like homeodomain 2
|
|
PKLR
|
pyruvate kinase, liver and RBC
|
|
PLAU
|
plasminogen activator, urokinase
|
|
PLCE1
|
phospholipase C, epsilon 1
|
|
PLEC
|
plectin
|
|
PLEKHA1
|
pleckstrin homology domain containing, family A (phosphoinositide binding specific) member 1
|
|
PON1
|
paraoxonase 1
|
|
PON2
|
paraoxonase 2
|
|
PON3
|
paraoxonase 3
|
|
POU4F3
|
POU class 4 homeobox 3
|
|
PPARG
|
peroxisome proliferator-activated receptor gamma
|
|
PPARGC1A
|
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha
|
|
PRKCA
|
protein kinase C, alpha
|
|
PRNP
|
prion protein
|
|
PROSER1
|
proline and serine rich 1
|
|
PROZ
|
protein Z, vitamin K-dependent plasma glycoprotein
|
|
PRPS1
|
phosphoribosyl pyrophosphate synthetase 1
|
|
PSCA
|
prostate stem cell antigen
|
|
PSMB8
|
proteasome (prosome, macropain) subunit, beta type, 8
|
|
PSMD9
|
proteasome (prosome, macropain) 26S subunit, non-ATPase, 9
|
|
PSORS1C1
|
psoriasis susceptibility 1 candidate 1
|
|
PSORS9
|
psoriasis susceptibility 9
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PTGS1
|
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTH1R
|
parathyroid hormone 1 receptor
|
|
PTK2
|
protein tyrosine kinase 2
|
|
PTPN22
|
protein tyrosine phosphatase, non-receptor type 22 (lymphoid)
|
|
PTPRC
|
protein tyrosine phosphatase, receptor type, C
|
|
RAB7A
|
RAB7A, member RAS oncogene family
|
|
RAMP2
|
receptor (G protein-coupled) activity modifying protein 2
|
|
RAPGEF3
|
Rap guanine nucleotide exchange factor (GEF) 3
|
|
RASGRP1
|
RAS guanyl releasing protein 1 (calcium and DAG-regulated)
|
|
RB1
|
retinoblastoma 1
|
|
RBFOX3
|
RNA binding protein, fox-1 homolog (C. elegans) 3
|
|
RBM8A
|
RNA binding motif protein 8A
|
|
RBP4
|
retinol binding protein 4, plasma
|
|
RCC1
|
regulator of chromosome condensation 1
|
|
RELN
|
reelin
|
|
REN
|
renin
|
|
RET
|
ret proto-oncogene
|
|
RETN
|
resistin
|
|
RGS1
|
regulator of G-protein signaling 1
|
|
RGS4
|
regulator of G-protein signaling 4
|
|
RNASEL
|
ribonuclease L (2',5'-oligoisoadenylate synthetase-dependent)
|
|
RNF185
|
ring finger protein 185
|
|
ROR2
|
receptor tyrosine kinase-like orphan receptor 2
|
|
RORC
|
RAR-related orphan receptor C
|
|
RPGR
|
retinitis pigmentosa GTPase regulator
|
|
RUNX1
|
runt-related transcription factor 1
|
|
RXRA
|
retinoid X receptor, alpha
|
|
RXRB
|
retinoid X receptor, beta
|
|
SCN1A
|
sodium channel, voltage gated, type I alpha subunit
|
|
SCN9A
|
sodium channel, voltage gated, type IX alpha subunit
|
|
SCNN1B
|
sodium channel, non voltage gated 1 beta subunit
|
|
SELP
|
selectin P (granule membrane protein 140kDa, antigen CD62)
|
|
SERPINC1
|
serpin peptidase inhibitor, clade C (antithrombin), member 1
|
|
SERPINE2
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 2
|
|
SERPING1
|
serpin peptidase inhibitor, clade G (C1 inhibitor), member 1
|
|
SFRP4
|
secreted frizzled-related protein 4
|
|
SFTPA2
|
surfactant protein A2
|
|
SGCE
|
sarcoglycan, epsilon
|
|
SH3TC2
|
SH3 domain and tetratricopeptide repeats 2
|
|
SHBG
|
sex hormone-binding globulin
|
|
SHFM1
|
split hand/foot malformation (ectrodactyly) type 1
|
|
SHOX
|
short stature homeobox
|
|
SLC11A1
|
solute carrier family 11 (proton-coupled divalent metal ion transporter), member 1
|
|
SLC1A1
|
solute carrier family 1 (neuronal/epithelial high affinity glutamate transporter, system Xag), member 1
|
|
SLC1A5
|
solute carrier family 1 (neutral amino acid transporter), member 5
|
|
SLC22A4
|
solute carrier family 22 (organic cation/zwitterion transporter), member 4
|
|
SLC22A5
|
solute carrier family 22 (organic cation/carnitine transporter), member 5
|
|
SLC24A2
|
solute carrier family 24 (sodium/potassium/calcium exchanger), member 2
|
|
SLC25A22
|
solute carrier family 25 (mitochondrial carrier: glutamate), member 22
|
|
SLC25A40
|
solute carrier family 25, member 40
|
|
SLC2A10
|
solute carrier family 2 (facilitated glucose transporter), member 10
|
|
SLC46A2
|
solute carrier family 46, member 2
|
|
SLC4A1
|
solute carrier family 4 (anion exchanger), member 1 (Diego blood group)
|
|
SLC4A11
|
solute carrier family 4, sodium borate transporter, member 11
|
|
SLC6A2
|
solute carrier family 6 (neurotransmitter transporter), member 2
|
|
SLC6A3
|
solute carrier family 6 (neurotransmitter transporter), member 3
|
|
SLC6A4
|
solute carrier family 6 (neurotransmitter transporter), member 4
|
|
SNCA
|
synuclein, alpha (non A4 component of amyloid precursor)
|
|
SOAT1
|
sterol O-acyltransferase 1
|
|
SORL1
|
sortilin-related receptor, L(DLR class) A repeats containing
|
|
SOX2
|
SRY (sex determining region Y)-box 2
|
|
SPATA7
|
spermatogenesis associated 7
|
|
SPRED1
|
sprouty-related, EVH1 domain containing 1
|
|
SPRED2
|
sprouty-related, EVH1 domain containing 2
|
|
SRC
|
SRC proto-oncogene, non-receptor tyrosine kinase
|
|
SRD5A2
|
steroid-5-alpha-reductase, alpha polypeptide 2 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 2)
|
|
SRGAP1
|
SLIT-ROBO Rho GTPase activating protein 1
|
|
SSTR5
|
somatostatin receptor 5
|
|
STAMBP
|
STAM binding protein
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
STK39
|
serine threonine kinase 39
|
|
STXBP5L
|
syntaxin binding protein 5-like
|
|
SULT1A1
|
sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1
|
|
SULT1A2
|
sulfotransferase family, cytosolic, 1A, phenol-preferring, member 2
|
|
SULT1B1
|
sulfotransferase family, cytosolic, 1B, member 1
|
|
SULT1E1
|
sulfotransferase family 1E, estrogen-preferring, member 1
|
|
SUSD6
|
sushi domain containing 6
|
|
TAF1
|
TAF1 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 250kDa
|
|
TAP2
|
transporter 2, ATP-binding cassette, sub-family B (MDR/TAP)
|
|
TCF19
|
transcription factor 19
|
|
TCF4
|
transcription factor 4
|
|
TCF7L2
|
transcription factor 7-like 2 (T-cell specific, HMG-box)
|
|
TCIRG1
|
T-cell, immune regulator 1, ATPase, H+ transporting, lysosomal V0 subunit A3
|
|
TDP1
|
tyrosyl-DNA phosphodiesterase 1
|
|
TEK
|
TEK tyrosine kinase, endothelial
|
|
TERF2IP
|
telomeric repeat binding factor 2, interacting protein
|
|
TG
|
thyroglobulin
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
TGFB3
|
transforming growth factor, beta 3
|
|
TGFBR2
|
transforming growth factor, beta receptor II (70/80kDa)
|
|
TGFBR3
|
transforming growth factor, beta receptor III
|
|
THADA
|
thyroid adenoma associated
|
|
TIMD4
|
T-cell immunoglobulin and mucin domain containing 4
|
|
TLR2
|
toll-like receptor 2
|
|
TLR4
|
toll-like receptor 4
|
|
TMC1
|
transmembrane channel-like 1
|
|
TMEM173
|
transmembrane protein 173
|
|
TMIE
|
transmembrane inner ear
|
|
TMPRSS2
|
transmembrane protease, serine 2
|
|
TNC
|
tenascin C
|
|
TNF
|
tumor necrosis factor
|
|
TNFRSF11B
|
tumor necrosis factor receptor superfamily, member 11b
|
|
TNFRSF1A
|
tumor necrosis factor receptor superfamily, member 1A
|
|
TNFRSF1B
|
tumor necrosis factor receptor superfamily, member 1B
|
|
TNFSF11
|
tumor necrosis factor (ligand) superfamily, member 11
|
|
TOM1
|
target of myb1 (chicken)
|
|
TOMM40
|
translocase of outer mitochondrial membrane 40 homolog (yeast)
|
|
TP73
|
tumor protein p73
|
|
TPH1
|
tryptophan hydroxylase 1
|
|
TPH2
|
tryptophan hydroxylase 2
|
|
TPO
|
thyroid peroxidase
|
|
TPSAB1
|
tryptase alpha/beta 1
|
|
TPSB2
|
tryptase beta 2 (gene/pseudogene)
|
|
TSHR
|
thyroid stimulating hormone receptor
|
|
TSLP
|
thymic stromal lymphopoietin
|
|
TTC12
|
tetratricopeptide repeat domain 12
|
|
TUBB3
|
tubulin, beta 3 class III
|
|
TUSC3
|
tumor suppressor candidate 3
|
|
TYMS
|
thymidylate synthetase
|
|
UBC
|
ubiquitin C
|
|
UGT1A1
|
UDP glucuronosyltransferase 1 family, polypeptide A1
|
|
UGT1A6
|
UDP glucuronosyltransferase 1 family, polypeptide A6
|
|
UGT1A7
|
UDP glucuronosyltransferase 1 family, polypeptide A7
|
|
UGT1A9
|
UDP glucuronosyltransferase 1 family, polypeptide A9
|
|
UGT2B15
|
UDP glucuronosyltransferase 2 family, polypeptide B15
|
|
UIMC1
|
ubiquitin interaction motif containing 1
|
|
USF1
|
upstream transcription factor 1
|
|
USH1C
|
Usher syndrome 1C (autosomal recessive, severe)
|
|
VCAN
|
versican
|
|
VCP
|
valosin containing protein
|
|
VDR
|
vitamin D (1,25- dihydroxyvitamin D3) receptor
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
VTN
|
vitronectin
|
|
VUR
|
Vesicoureteral reflux
|
|
VWF
|
von Willebrand factor
|
|
WFS1
|
Wolfram syndrome 1 (wolframin)
|
|
WNK3
|
WNK lysine deficient protein kinase 3
|
|
WWOX
|
WW domain containing oxidoreductase
|
|
XRCC1
|
X-ray repair complementing defective repair in Chinese hamster cells 1
|
|
ZFHX3
|
zinc finger homeobox 3
|
|
ZHX1
|
zinc fingers and homeoboxes 1
|
|
ZNF804A
|
zinc finger protein 804A
|
|
ZPR1
|
ZPR1 zinc finger
|
|
ZRANB1
|
zinc finger, RAN-binding domain containing 1
|
